Navigation Links
Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate
Date:10/27/2011

2.9: Future scenarios for pharmaceutical pricing and reimbursement in the US 54

Figure 3.10: Pharmaceutical price controls in major European markets 61

Figure 3.11: Pharmaceutical reimbursement systems in major European markets 62

Figure 3.12: Italian categorization for innovative new therapies 69

Figure 3.13: Future scenarios for pharmaceutical pricing and reimbursement in the major European markets 84

Figure 4.14: The Japanese National Health Insurance system, FY2008 92

Figure 4.15: Average NHI price cuts, 1998-2008 95

Figure 4.16: Future scenarios for pharmaceutical pricing and reimbursement in Japan 99

Figure 4.17: Real GDP growth in BRIC and major markets, 2008 103

Figure 5.18: International price differentials for leading drugs, 2008 110

Figure 5.19: Market share for new products launched in last five years, 2007 112

Figure 5.20: Delays in European market access, 2007 114

Figure 5.21: External reference pricing in Europe, 2009 116

Figure 5.22: Parallel imports as a share of pharmacy sales in Europe, 2007 118

Figure 6.23: Price demand and response curves 128

Figure 6.24: Market share and revenue impact of reimbursement and formulary status 130

Figure 6.25: Budget impact modeling 135

List of Tables

Table 1.1: Trends in healthcare spend as a proportion of GDP, 1990-2007 20

Table 1.2: Number of NME and BLA approvals by the FDA, 1999-2008 24

Table 1.3: R&D expenditure by PhRMA members, 1999-2008 26

Table 4.4: NHI price premium classifications for new drugs 93

Table 6.5: Pricing across the drug development and marketing lifecycle 137

To order this report:

Pharmaceutical Industry:

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013   Life Technologies Corporation ... licensing agreement granting Suzhou Ribo Life Sciences (Ribo) ... therapeutics in China using ... proprietary siRNA molecules in combination with Invivofectamine® Rx ... human diseases with high unmet medical need in ...
(Date:6/19/2013)... 19. Juni 2013 Specialty ... der Entwicklung von SCS microRESIST™, einer ... der Beschichtung mit Parylene gelungen ist. ... biokompatiblem Parylene mit antimikrobiellen Eigenschaften und ... Mikroorganismen auf beschichteten medizinischen Geräten. ...
(Date:6/18/2013)... 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... the development and commercialization of novel bile acid therapeutics ... of an underwritten public offering of 1,730,000 shares of ... $33.01 per share.  In addition, Intercept has granted the ... additional 259,500 shares of common stock. All ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
(Date:6/19/2013)... The former internist for the St. Louis ... serves as director of prevention and wellness at St. ... personal encounter with a metabolic syndrome diagnosis and a ... , that he credits with sparking the paradigm-shift that ... practice. , “The average medical student gets 30 minutes ...
(Date:6/19/2013)... Recently, SoCal CEO Magazine staff was on hand ... in a series of six workshops where people with and without ... the mosaic tiles in their permanent location under the direction of ... Maxwell. , This mural project began in March of 2013 ... three years ago with the goal of promoting ...
(Date:6/19/2013)... The US Food and Drug Administration (FDA) announced ... breast implant, Mentor Worldwide’s MemoryShape™. , The FDA approved Sientra/Silimed ... FDA announced the approval of the MemoryShape™ implant on June ... in women 22 years old or older and in ... FDA’s approval comes after six years of data from 955 ...
(Date:6/19/2013)... the mantra of neurologists treating stroke victims has been "time ... room quickly to receive a drug that dissolves the stroke-causing ... brain tissue is saved or lost. , But ... of giving the intravenous drug known as a tissue ... ischemic (clot-caused), stroke, the most common type of stroke. ...
(Date:6/19/2013)... fact that the incidence of cancer is many fold ... still have an inadequate understanding on how best to ... patients are occasionally included in clinical trials, those elderly ... elderly patients. Thus, the broader elderly patient population is ... in the Elderly Task Force is now starting a ...
Breaking Medicine News(10 mins):Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 2Health News:Plant-based Nutrition is Key to Health Transformation of St. Luke’s Hospital Director of Prevention and Wellness 3Health News:Arc Creates Huge Mosaic Mural to Highlight the Need for Greater Respect of People with Disabilities 2Health News:FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 2Health News:Timely treatment after stroke is crucial, UCLA researchers report 3Health News:EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer 2
... The study team involving researchers from the U.S. Army ... Microbiology Laboratory// at the Public Health Agency of Canada ... protect monkeys by in preventing hemorrhagic fever in monkeys ... Could also provide the first known treatment for the ...
... psychologist and Professor Saul Shiffman has revealed that people who ... likely to bounce back to a complete relapse, if they ... in Smoking Cessation: Illustration in a Nicotine Patch Trial in ... in the Journal of Consulting and Clinical Psychology. ...
... not offer protection against cardiovascular disease, despite the lofty ... trial has shown.// The findings of the trial have ... American Journal of Epidemiology. ,Selenium now joins the ... particular, that were praised for its role in preventing ...
... go a long way in increasing the life expectancy of ... smoking,// exercising more and eating better could increase your life ... ,Researchers led by Professor Kay-Tee Khaw studied 25,663 men and ... in Norfolk and found small lifestyle changes could have a ...
... open a second cancer hospital, this time in the southern ... up in Karachi by January next year, the Daily Times ... had set up the Shaukat Khanum Memorial Cancer Hospital and ... state-of-the-art cancer centre was Khan's tribute to his mother Shaukat ...
... health officials are demanding the government to take radical ... Lynne Kosky announced// a ban on high-sugar soft drinks ... Haikerwal said that this was not going to change ... measures. ,He said that the present generation ...
Cached Medicine News:Health News:New Vaccine To Combat The Deadly Marburg Virus 2
Angulation, translation and rotation. A whole different point of view. The Sheffield Ring Fixation System is a design achievement that advances the possibilities of fracture management....
For radial/ulnar translation, angulation, dorsal/volar translation, and incremental longitudinal distraction, this advanced system is appropriate when incremental adjustment provides an adjunctive me...
The Small External Fixator has straight or angled frames, independent pin placement, and combines easily with Large and Medium External Fixator frames....
... Fixation System for distal radius fractures allows ... length and rotation. The unique wrist lock ... into extension without losing fracture reduction. Post-op ... the surgeons office. Priced competitively and sold ...
Medicine Products: